Company Profile
 |
Arthritis Relief Plus (ARP) Limited ARP is a Queensland, Australia-based, unlisted public company. ARP owns the rights to commercialise Acteev®, a novel formulation that has patent protection pending. ARP is commercialising Acteev® for a variety of human and animal degenerative joint conditions, including osteoarthritis, cervical and lumbar spondylitis.
Phone: 0404 272 365 | Fax: 07 5571 2202
Biotechnology Categories
|